← Feed

Robb Gary Charles

SEC Form 4 insider
Chief Business Officer · CORCEPT THERAPEUTICS INC ($CORT)
1 thesis · first seen Aug 14, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$CORTSEC Form 4bearish
Robb Gary Charles · Chief Business Officer at CORCEPT THERAPEUTICS INC · 6h agono track record yet
Sold 10,000 @ $116.26 avg · $1,162,572 · 2026-08-17

Form 4: Robb Gary Charles sold CORT

Robb Gary Charles (Chief Business Officer at CORCEPT THERAPEUTICS INC) reported an open-market sale of 10,000 shares of CORT at an average $116.26, roughly $1,162,572, in a Form 4 filed 2026-08-18.

View filing on SEC.gov →

End of results.